304 related articles for article (PubMed ID: 24099942)
1. Effect of preparation parameters on ultra low molecular weight chitosan/hyaluronic acid nanoparticles.
Nazeri N; Avadi MR; Faramarzi MA; Safarian S; Tavoosidana G; Khoshayand MR; Amani A
Int J Biol Macromol; 2013 Nov; 62():642-6. PubMed ID: 24099942
[TBL] [Abstract][Full Text] [Related]
2. Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.
Lu HD; Zhao HQ; Wang K; Lv LL
Int J Pharm; 2011 Nov; 420(2):358-65. PubMed ID: 21911044
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation.
Almalik A; Donno R; Cadman CJ; Cellesi F; Day PJ; Tirelli N
J Control Release; 2013 Dec; 172(3):1142-50. PubMed ID: 24103813
[TBL] [Abstract][Full Text] [Related]
5. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
6. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
Fan W; Yan W; Xu Z; Ni H
Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934
[TBL] [Abstract][Full Text] [Related]
7. Exploring the assembly process and properties of novel crosslinker-free hyaluronate-based polyelectrolyte complex nanocarriers.
Umerska A; Paluch KJ; Inkielewicz-Stępniak I; Santos-Martinez MJ; Corrigan OI; Medina C; Tajber L
Int J Pharm; 2012 Oct; 436(1-2):75-87. PubMed ID: 22814226
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
[TBL] [Abstract][Full Text] [Related]
9. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
10. HA-coated chitosan nanoparticles for CD44-mediated nucleic acid delivery.
Almalik A; Day PJ; Tirelli N
Macromol Biosci; 2013 Dec; 13(12):1671-80. PubMed ID: 24106105
[TBL] [Abstract][Full Text] [Related]
11. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
Umerska A; Corrigan OI; Tajber L
Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822
[TBL] [Abstract][Full Text] [Related]
12. Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.
Verheul RJ; Slütter B; Bal SM; Bouwstra JA; Jiskoot W; Hennink WE
J Control Release; 2011 Nov; 156(1):46-52. PubMed ID: 21784113
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid/chitosan nanoparticles for delivery of curcuminoid and its in vitro evaluation in glioma cells.
Yang L; Gao S; Asghar S; Liu G; Song J; Wang X; Ping Q; Zhang C; Xiao Y
Int J Biol Macromol; 2015 Jan; 72():1391-401. PubMed ID: 25450553
[TBL] [Abstract][Full Text] [Related]
14. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
Liu Z; Jiao Y; Liu F; Zhang Z
J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles.
Duceppe N; Tabrizian M
Biomaterials; 2009 May; 30(13):2625-31. PubMed ID: 19201022
[TBL] [Abstract][Full Text] [Related]
16. Facile preparation of well-defined near-monodisperse chitosan/sodium alginate polyelectrolyte complex nanoparticles (CS/SAL NPs) via ionotropic gelification: a suitable technique for drug delivery systems.
Liu P; Zhao X
Biotechnol J; 2013 Jul; 8(7):847-54. PubMed ID: 23625874
[TBL] [Abstract][Full Text] [Related]
17. Improving the osteogenesis of rat mesenchymal stem cells by chitosan-based-microRNA nanoparticles.
Wu G; Feng C; Hui G; Wang Z; Tan J; Luo L; Xue P; Wang Q; Chen X
Carbohydr Polym; 2016 Mar; 138():49-58. PubMed ID: 26794737
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-hyaluronic acid nanoparticles for gene silencing: the role of hyaluronic acid on the nanoparticles' formation and activity.
Al-Qadi S; Alatorre-Meda M; Zaghloul EM; Taboada P; Remunán-López C
Colloids Surf B Biointerfaces; 2013 Mar; 103():615-23. PubMed ID: 23274155
[TBL] [Abstract][Full Text] [Related]
19. Response Surface Methodology for Statistical Optimization of Chitosan/Alginate Nanoparticles as a Vehicle for Recombinant Human Bone Morphogenetic Protein-2 Delivery.
Zohri M; Akbari Javar H; Gazori T; Khoshayand MR; Aghaee-Bakhtiari SH; Ghahremani MH
Int J Nanomedicine; 2020; 15():8345-8356. PubMed ID: 33154637
[TBL] [Abstract][Full Text] [Related]
20. Towards better modeling of chitosan nanoparticles production: screening different factors and comparing two experimental designs.
Abdel-Hafez SM; Hathout RM; Sammour OA
Int J Biol Macromol; 2014 Mar; 64():334-40. PubMed ID: 24355618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
